Sanofi-Aventis SA Company Information
Employees at Sanofi-Aventis SA
Showing 15 of 67383| JOB TITLE | WORK EMAIL | WORK PHONE | LOCATION | |
|---|---|---|---|---|
| Pharmareferentin | @sanofi.com | - |
VIEW PROFILE | |
| Employee | @sanofi.com | - |
VIEW PROFILE | |
| Employee | @astrazeneca.com | - |
North Carolina | VIEW PROFILE |
| Technicienne Supérieure Archiviste | @sanofi.com | - |
Montpellier, Languedoc-Roussillon | VIEW PROFILE |
| Regional Medical Liaison | @sanofi.com | - |
Wichita, Kansas | VIEW PROFILE |
| Manager | @sanofi.com | - |
VIEW PROFILE | |
| Medical Director | @sanofi.com | - |
VIEW PROFILE | |
| Senior Director, Head Of Operations, Global Market Access | @sanofi.com | - |
New Jersey | VIEW PROFILE |
| Pharmaceutical Sales Representative | @sanofi.com | - |
California | VIEW PROFILE |
| General Therapeutics and Life Cycle Management | @sanofi.com | +1 (908) 243-xxxx | New Jersey | VIEW PROFILE |
| Employee | @astrazeneca.com | - |
VIEW PROFILE | |
| Trainee | @alcimed.com | - |
VIEW PROFILE | |
| Assistant Manager | @sanofi.com | - |
VIEW PROFILE | |
| Technical Lead | @sanofi.com | - |
New York, New York | VIEW PROFILE |
| Employee | @astrazeneca.com | - |
VIEW PROFILE |
Pharmareferentin
Employee
Employee
North Carolina Technicienne Supérieure Archiviste
Montpellier, Languedoc-Roussillon Regional Medical Liaison
Wichita, Kansas Manager
Medical Director
Senior Director, Head Of Operations, Global Market Access
New Jersey Pharmaceutical Sales Representative
California 
Employee
Trainee
Assistant Manager
Technical Lead
New York, New York Employee
Enter an employee name to search and verify work emails, phone numbers and social links etc.
Sanofi-Aventis SA's Email Format
We found 3 email formats used by Sanofi-Aventis SA employees. The most common Sanofi-Aventis SA email format is first.last ex.(jane.doe@sanofi.com) being used 93% of the time.
| FORMAT | % | ||
|---|---|---|---|
| First.last | jane.doe@sanofi.com | 93% | |
| First_initial Last | jdoe@sanofi.com | 3% | |
| Others | @sanofi.com | 2% |
